World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 17 October 2016
Main ID:  ISRCTN53264564
Date of registration: 20/01/2014
Prospective Registration: No
Primary sponsor: Gynius AB (Sweden)
Public title: Cervical Swede score screening by colposcope and the Gynocular
Scientific title: The Bangladesh Swede score Gynocular clinical trial
Date of first enrolment: 01/06/2012
Target sample size: 540
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN53264564
Study type:  Interventional
Study design:  Crossover randomized clinical trial (Screening)  
Phase: 
Countries of recruitment
Bangladesh
Contacts
Name: Ashrafun    Nessa
Address:  Department of Obstetrics and Gynecology Bangabandhu Sheikh Mujib Medical University Hospital (BSMMU) Shabag 1000 Dhaka Bangladesh
Telephone:
Email:
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Women positive for acetic acid (VIA) at opportunistic screening by trained family welfare visitors, senior staff nurses and doctors in the Dhaka region, Bangladesh, referred for colposcopy at the Colposcopy Clinic of Bangabandhu Sheikh Mujib Medical University (BSMMU). A women is considered to be VIA positive when a trained doctor or nurse noticed sharp, distinct, well defined, dense acetowhite areas on the cervix, with or without raised margins, close to the squamocolumnar junction (SCJ) in the transformation zone 6-9, 15.
2. Women signing an informed consent to participate in the study after receiving oral and written information from a social worker
3. Ability to understand written and oral information

Exclusion criteria: 1. Ongoing vaginal bleeding
2. Any previous gynecological examinations for at least one week before
3. Pregnancy


Age minimum:
Age maximum:
Gender: Female
Health Condition(s) or Problem(s) studied
Cervical screening Colposcopy Swede score
Urological and Genital Diseases
Intervention(s)
Patients were randomized to two groups:
Group 1 were examined with the hand-held colposcope, the Gynocular
Group 2 were examined with a stationary colposcope

Participants were then crossed over. Those randomized to Group 1 were examined with the stationary colposcope and Group 2 were examined using the Gynocular. Women who had a positive cytology or cervical biopsy with high-grade cervical dysplasia were offered treatment at BSMMU.
Primary Outcome(s)
Compare if a hand-held colposcope, the Gynocular, could detect cervical lesions equal to a stationary colposcope
Secondary Outcome(s)
To evaluate the performance of Swede score to detect cervical lesions in VIA-positive women, and detection rates of HPV
Secondary ID(s)
N/A
Source(s) of Monetary Support
Gynius AB (Sweden), H&M Conscious Foundation (Sweden)
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history